Ins&Outs receives Australian TGA clearance

Amazing Gut is delighted to announce that it has received Australia Theraputics Goods Administration (TGA) 510 clearance for the Ins&Out System, paving the way for its first product to be marketed and sold in Australia.

This breakthrough milestone is another significant step in Amazing Gut’s commercial execution plan to bring the product to a wider audience of healthcare providers and patients.

Ins&outs offers patients effective anorectal biofeedback therapy from the convenience and privacy of their homes. Anorectal biofeedback therapy is the first-line treatment for functional constipation (dyssynergic defaecation, anismus), faecal incontinence, and anal pain (levator ani syndrome) demonstrated to provide long-term relief in up 90% of patients.

Functional bowel disorders affect 1 in 5 individuals worldwide, not only does cause physical distress but also significantly impacting mental and social well-being. The TGA clearance enables Amazing Gut to address a large unmet clinical need in accessing biofeedback therapy, which can lead to disease progression.

“We are thrilled to have achieved TGA clearance, signifying a important step in improving the bowels of millions of Australian” said Dr Jerry, CEO & Co-founder of Amazing Gut. “Ins&Outs is a much-needed treatment that gives patients the option to undergo therapy conveniently, quickly, and effectively.”

Ins&Outs will be available commercially in Australia from January 2026.